Phase I study of extended release bupivacaine/meloxicam [HTX 011] in volunteers

Trial Profile

Phase I study of extended release bupivacaine/meloxicam [HTX 011] in volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 19 Mar 2015

At a glance

  • Drugs Bupivacaine/meloxicam (Primary)
  • Indications Postoperative pain
  • Focus Adverse reactions
  • Sponsors Heron Therapeutics
  • Most Recent Events

    • 19 Mar 2015 Results published in a Heron Therapeutics media release.
    • 11 Feb 2015 This trial has been initiated and initial results are expected before the end of the first quarter of 2015, according to a Heron Therapeutics media release.
    • 11 Feb 2015 Status changed from planning to recruiting, according to a Heron Therapeutics media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top